Showing results (1511-1520 of 1,568) with videos related to

Sort By:
Pageof 157
Cell Reports|January 21, 2014
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell stateYakov Chudnovsky, Dohoon Kim, Siyuan Zheng, et al.
Head & Neck|June 24, 2014
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smokeRyan Li, Daniel L Faden, Carole Fakhry, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective StudyAlessandro Orsini, Thomas Foiadelli, Attilio Sica, et al.
Cancer Discovery|March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Blood|February 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
JCO Precision Oncology|June 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTOBrian W Labadie, Aleksandar Obradovic, Alexander G Raufi, et al.
European Journal of Haematology|September 16, 2025
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter StudyMaria Carmen Martorelli, Novella Pugliese, Maria Di Perna, et al.
Cell|February 1, 2024
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasionGiuseppe Leuzzi, Alessandro Vasciaveo, Angelo Taglialatela, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2021
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trialRaimondo Di Liello, Laura Arenare, Francesco Raspagliesi, et al.
JTO Clinical and Research Reports|January 13, 2025
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World StudyLaura Moliner, Núria Zellweger, Sabine Schmid, et al.
Pageof 157